The main reason that EMH stock has surged is because the industry was in store for a bounce back, with some stocks reaping more gains than others. Marijuana stocks had fallen to such a point that the market once again became bullish on them in an ebb-and-flow dance we’ve seen repeated many times now.
Full Answer
Is emerald health Therapeutics (emhtf) outperforming other stocks this year?
Emerald Health Therapeutics has received 58.93% “outperform” votes from our community. MarketBeat's community ratings are surveys of what our community members think about Emerald Health Therapeutics and other stocks. Vote “Outperform” if you believe EMHTF will outperform the S&P 500 over the long term.
What is emerald health Therapeutics'days-to-cover ratio?
Based on an average daily trading volume, of 550,900 shares, the days-to-cover ratio is currently 0.2 days. View Emerald Health Therapeutics' Short Interest. Who are Emerald Health Therapeutics' key executives? Who are some of Emerald Health Therapeutics' key competitors?
Where is emerald health Therapeutics located?
Emerald Health Therapeutics is headquartered at 800 West Pender Street, Vancouver, BC V6C. How can I contact Emerald Health Therapeutics? Emerald Health Therapeutics' mailing address is 800 West Pender Street, Vancouver, BC V6C. The company can be reached via phone at (800) 757-3536.
How much is a share of emhtf worth?
One share of EMHTF stock can currently be purchased for approximately $0.05. How many employees does Emerald Health Therapeutics have? Emerald Health Therapeutics employs 110 workers across the globe.
See more
What is going on with Emerald Health Therapeutics?
Emerald Health Therapeutics plans to exit Canada's recreational and medical cannabis sectors after racking up more than 200 million Canadian dollars ($156 million) in losses since its inception. The Victoria, British Columbia-based business is the first mass-producer to choose to exit the cannabis industry.
Is Emerald Health Therapeutics a good stock to buy?
Emerald Health Therapeutics is a small-cap stock with a high ceiling, which has attracted its fair share of would-be investors. The company has already demonstrated that it's capable of strong and rapid growth.
Is Emerald Health pharmaceuticals publicly traded?
EHP is currently offering shares of Common Stock at $6.00 per share to both accredited and nonaccredited investors. The minimum investment is 500 shares, or $3,000. The Company's Offering Circular, which was qualified by the SEC on November 24, 2020, can be viewed by clicking here.
How has Emerald Health Therapeutics' stock price performed in 2022?
Emerald Health Therapeutics' stock was trading at $0.0450 at the start of the year. Since then, EMHTF shares have decreased by 17.8% and is now tra...
Are investors shorting Emerald Health Therapeutics?
Emerald Health Therapeutics saw a increase in short interest in May. As of May 31st, there was short interest totaling 423,400 shares, an increase...
Who are Emerald Health Therapeutics' key executives?
Emerald Health Therapeutics' management team includes the following people: Mr. Moe Jiwan , Chief Operating Officer Mr. Bernie Hertel , VP of Fi...
Who are some of Emerald Health Therapeutics' key competitors?
Some companies that are related to Emerald Health Therapeutics include 18564 (NBL.L) (NBL) , Cooper Energy (COPJF) , Crown Point Energy (CWVLF)...
What is Emerald Health Therapeutics' stock symbol?
Emerald Health Therapeutics trades on the OTCMKTS under the ticker symbol "EMHTF."
How do I buy shares of Emerald Health Therapeutics?
Shares of EMHTF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBu...
What is Emerald Health Therapeutics' stock price today?
One share of EMHTF stock can currently be purchased for approximately $0.04.
How many employees does Emerald Health Therapeutics have?
Emerald Health Therapeutics employs 110 workers across the globe.
What is Emerald Health Therapeutics' official website?
The official website for Emerald Health Therapeutics is www.emerald.care .
What is Emerald Health Therapeutics' stock symbol?
Emerald Health Therapeutics trades on the OTCMKTS under the ticker symbol "EMHTF."
Where are Emerald Health Therapeutics' headquarters?
Emerald Health Therapeutics is headquartered at 800 West Pender Street, Vancouver, BC V6C.
What is MarketBeat community ratings?
MarketBeat's community ratings are surveys of what our community members think about Emerald Health Therapeutics and other stocks. Vote “Outperform” if you believe EMHTF will outperform the S&P 500 over the long term. Vote “Underperform” if you believe EMHTF will underperform the S&P 500 over the long term. You may vote once every thirty days.
What is the ticker symbol for Emerald Health Therapeutics?
Emerald Health Therapeutics trades on the OTCMKTS under the ticker symbol "EMHTF."
Where is Emerald Health located?
The firm engages in the production distribution, and sale of cannabis products. Its products include dried cannabis and cannabis oil, pants and seeds. The company was founded on Jul 31, 2007 and is headquartered in Vancouver, Canada.
Does Emerald Health Therapeutics pay dividends?
Emerald Health Therapeutics does not currently pay a dividend.
The closer we get to the green rush, the more red this pot stock seems to produce
In less than six weeks, the day that cannabis enthusiasts and investors have long waited for will finally be here. That's right: Recreational marijuana will officially be legal for sale in Canada on Oct. 17. And with this legalization will come an opportunity for the weed industry to bring in billions of dollars annually, once fully ramped up.
1. Capacity expansion remains on track
Though Emerald Health's second-quarter report does highlight its top- and bottom-line results, most of its press release is devoted to its ongoing expansion projects and its outlook. The good news here is that its capacity expansion remains on track.
2. Supply deals are being signed
However, it's about more than just supply. Marijuana stocks need to be able to find buyers for all the cannabis they're producing, and in this respect, we're beginning to see Emerald Health Therapeutics make headway.
3. Inventory levels more than doubled
As we barrel toward legalization, another important number to watch is the inventory level for growers.
4. It's (apparently) hungry for acquisitions and partnerships
Like many of its peers, Emerald Health has also been growing inorganically and through the help of strategic partnerships. During the recently ended quarter, it completed the acquisition of Agro Biotech for CA$90 million, which was paid half in cash and half in common stock.
5. Emerald Health is well capitalized
Investors should understand that Emerald Health Therapeutics isn't the least bit concerned about how it'll pay for its ongoing capacity expansion, acquisitions, and partnerships.
6. Things will get fundamentally worse, before they get better
On the other hand, costs have been rising quickly for Emerald Health Therapeutics as it expands its capacity and gets its much-needed infrastructure in place.
The case for Emerald Health Therapeutics
Probably the strongest argument for buying Emerald Health Therapeutics stock is the company's 50% ownership in Pure Sunfarms, a joint venture with Village Farms International. Pure Sunfarms contributed 86% of Emerald Health's total revenue in the second quarter. And that percentage could move even higher.
The case for Green Thumb Industries
It's not hard to figure out why Green Thumb Industries (GTI) has enjoyed such nice share gains so far this year. The company reported 228% year-over-year revenue growth in the second quarter. Sales soared 60% over the previous quarter.
Better marijuana stock
As mentioned earlier, historical performance isn't always a great predictor of future success. In this case, however, I'd go with the past track record. Green Thumb Industries looks like the better pick over Emerald Health Therapeutics.
Premium Investing Services
Invest better with the Motley Fool. Get stock recommendations, portfolio guidance, and more from the Motley Fool's premium services.
